1. Home
  2. ALXO

as 06-13-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Founded: 2015 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 469.4M IPO Year: 2020
Target Price: $20.50 AVG Volume (30 days): 666.6K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.71 EPS Growth: N/A
52 Week Low/High: $3.94 - $17.83 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

ALXO Daily Stock ML Predictions

Stock Insider Trading Activity of ALX Oncology Holdings Inc. (ALXO)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Pons Jaume ALXO PRESIDENT & CSO Jun 4 '24 Sell $8.43 20,000 $168,652.00 604,205 SEC Form 4
Randolph Sophia ALXO CHIEF MEDICAL OFFICER May 13 '24 Sell $15.82 10,203 $161,379.83 332,146 SEC Form 4
Randolph Sophia ALXO CHIEF MEDICAL OFFICER May 13 '24 Sell $16.67 1,797 $29,958.87 330,349 SEC Form 4
Pons Jaume ALXO PRESIDENT & CSO Apr 16 '24 Sell $14.20 50,000 $710,195.00 604,205 SEC Form 4
Pons Jaume ALXO PRESIDENT & CSO Apr 4 '24 Sell $11.15 20,000 $223,036.00 628,359 SEC Form 4
Lettmann Jason ALXO CHIEF EXECUTIVE OFFICER Mar 14 '24 Buy $11.31 4,400 $49,771.48 171,620 SEC Form 4
Pinto Shelly ALXO SVP, Finance and CAO Jan 4 '24 Sell $13.60 2,717 $36,956.63 78,591 SEC Form 4
Pons Jaume ALXO President & CSO Dec 29 '23 Sell $15.04 7,179 $107,972.16 618,359 SEC Form 4
Pinto Shelly ALXO SVP, Finance and CAO Dec 29 '23 Sell $15.04 1,631 $24,530.24 81,308 SEC Form 4
GARCIA PETER S ALXO Chief Financial Officer Dec 29 '23 Sell $15.04 1,893 $28,470.72 85,348 SEC Form 4
Randolph Sophia ALXO Chief Medical Officer Dec 29 '23 Sell $15.04 3,128 $47,045.12 312,349 SEC Form 4

Share on Social Networks: